Emerging contaminants, such as pharmaceuticals, personal care products, and endocrine disruptors, present unique challenges for regulatory agencies. These substances often lack comprehensive toxicological data, necessitating precautionary approaches. Regulatory frameworks are evolving to include monitoring programs and research initiatives aimed at understanding the environmental and health impacts of these emerging contaminants.
